Navigation Links
Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
Date:4/15/2008

Tasker's Clear product will be marketed from the Scalder to the Post-Chill

Dip and Spray

FAIR LAWN, N.J., April 15 /PRNewswire-FirstCall/ -- Tasker Products Corp. (OTC Bulletin Board: TKER), a distributor and marketer of proprietary technology effective in inhibiting pathogenic bacteria, today announced that it has received a "Letter of No Objections" from the Food Safety and Inspection Service ("FSIS") of the United States Food and Drug Administration ("USDA") to market its patented Tasker Clear in all sections of poultry processing.

Currently, poultry processors use various acidifiers to control the pH levels of poultry intervention systems. These acidifiers predominately come in dry, powder form that can be corrosive and cumbersome to use in a plant environment and are more expensive and less friendly than liquid solutions. Tasker Clear is an effective acidifier in liquid form, making it easier and less expensive to administer under complex processing conditions.

Commenting on the latest progress, Lanny Dacus, Tasker's president and CEO, said, "This is a major achievement for Tasker. With the poultry processing relationships we have established over the last 18 months, we now have a new product to market that can be immediately deployed and is in wide demand. Our new Tasker Clear product is the only acidifier available in aqueous form. It is highly concentrated, effective and cost competitive. We are excited to receive such a complete response from the USDA. The regulatory consent of this product extends our marketing effort in the poultry industry to include approximately 50 turkey plants, and possibly red meat plants. The quick response received from the USDA on Tasker Clear may accelerate the review, and possible approval, of Tasker's application for red meat."

Tasker Products also has poultry processing applications for its Tasker Blue product. Tasker Blue uses acidified copper sulfate in a patented process to reduce all forms of pathogenic bacteria. The company has received approvals from the USDA to test Tasker Blue in the chiller, post-chiller dip and post-chiller spray applications. The Company previously received a Letter of No Objections from the USDA for its Tasker Blue application for the scalder section of poultry processing, which it is currently marketing; however, the recent postponement of stricter regulatory requirements for the scalder has impacted the Company's marketing strategy in the short term.

Mr. Dacus added, "We plan to be in the market with our Tasker Clear immediately, and expect the product to have a positive impact on our second quarter results."

About Tasker Products

Tasker is a manufacturer, distributor and marketer of acid-based eco-chemistry products. The Company currently markets Unifresh(R) Footbath products for dairy cows, Tasker Blue(R) and Tasker Clear, antibacterial solutions for use in processing poultry, and Pacific Blue(TM) Seafood Spray, an antibacterial spray for retail seafood counters. Tasker Products Corp. is headquartered in Fair Lawn, New Jersey. To be added to the news distribution list or to present any questions, send an email to tasker@grannusfinancial.com. Additional information about Tasker is also available at http://www.taskerproducts.com.

This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to obtain new financing and/or generate revenue growth in the near future; our history of losses; our limited experience in the marketing of our products; our ability to compete with other products in our market space; and the risk of unfavorable federal regulation. Consequently, you should not place undue reliance on these forward-looking statements. We discuss these and other risks and uncertainties in greater detail in the filings we make with the Securities and Exchange Commission, including under the section entitled, "Risk Factors" in the Company's Annual Report on Form 10-K, as amended, for the year ended December 31, 2006 and our most recent report on Form 10-Q.

Investor Contact:

Grannus Financial Advisors, Inc. (212-681-4100)

or

taskerproducts@grannusfinancial.com


'/>"/>
SOURCE Tasker Products Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Tasker Products Rolls Out Scalder Application at Two New Poultry Processors Facilities
2. Healthy Diabetic Bakery Products Launched Nationally
3. Gardasil, Other New Products Spur Strong Vaccine Sales in 2007
4. London Luxury LLC Announces Exclusive Partnership with Cupron, Inc., to Develop Innovative Copper-Infused Bed and Bath Products
5. Zimmer Announces Actions Affecting its Ohio-based Orthopaedic Surgical Products Operation
6. Sonic Innovations Launches Two New Hearing Aid Products in Conjunction With Companys 10-Year Anniversary
7. Natural Elements Reveals Exotic Natural Hawaiian Skin Care Products for Sale on Their Website
8. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
9. Schiff(R) Introduces New Supplement Products for Intestinal Health and Beauty Maintenance
10. Sergeants(R) Pet Care Products Acquires the Consumer Brand Division of Virbac Corporation
11. House Health Subcommittee Acts to Protect Kids and Save Lives by Approving Bill to Regulate Tobacco Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: